Mirum Pharmaceuticals (MIRM) Raw Materials (2021 - 2026)

Mirum Pharmaceuticals' Raw Materials history runs 6 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Raw Materials fell 13.68% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 13.68% YoY), while the FY2025 annual figure was $2.9 million, down 4.36% from the prior year.
• Raw Materials was $2.6 million for Q1 2026 at Mirum Pharmaceuticals, down from $2.9 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $3.0 million in Q4 2024 to a low of $444000.0 in Q3 2023.
• Historically, Raw Materials has averaged $2.5 million across 5 years, with a median of $2.9 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Raw Materials jumped 528.38% in 2024, then declined 13.68% in 2026.
• A 5-year view of Raw Materials shows it stood at $858000.0 in 2022, then surged by 249.42% to $3.0 million in 2023, then climbed by 1.07% to $3.0 million in 2024, then declined by 4.36% to $2.9 million in 2025, then declined by 9.87% to $2.6 million in 2026.
• The last three Raw Materials figures came in at $2.6 million (Q1 2026), $2.9 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.